Regulators of Astrocyte Proliferation Identified

Researchers from Helmholtz Munich and the Ludwig-Maximilians-Universität München have determined that astrocytes become active during disease situations, and often exhibit properties of neural stem cells. In addition to this discovery is the parallel identification of a protein that regulates these cells, and could potentially serve as a target for future therapies.

Published in Nature Medicine, the research sheds light on the nuanced reactions of astrocytes in various injury conditions. The study emphasizes the specificity of astrocyte reactions and their potential to transform into neural stem cells, offering a glimpse into a novel strategy for mitigating irreversible neuronal loss caused by trauma, stroke, epilepsy, and neurodegenerative diseases.

Neurological disorders pose a significant challenge, leading to irreversible neuronal loss and substantial impairments in brain function. Current treatment options are limited due to the inability to replace lost neurons and the unsupportive injury environment for recovery. However, previous preclinical research has hinted at the promise held by astrocytes, which have demonstrated the ability to resume cell proliferation, shielding the injured brain from immune cell invasion.

The research team also found that astrocytes in the adult human brain exhibit proliferation and acquire neural stem cell properties in response to a disease-related disruption of the blood-brain barrier. The study identified a protein, Galectin 3, as a marker for proliferating human astrocytes, offering diagnostic relevance and contributing to understanding diagnosis-specific changes in cerebrospinal fluid composition.

Dr. Swetlana Sirko, the study's first author, emphasized the diagnostic significance of their findings, stating that the identification of the Galectin 3-LGALS3BP axis could contribute significantly to predicting proliferative astrogliosis and modulating these reactions in the affected brain.

By unveiling two pivotal regulators of astrocyte proliferation, the researchers have laid the foundation for future clinical applications, potentially using these biomarkers as indicators for beneficial glial cell reactions. Most notably, the study identifies the presence of cells with stem cell potential in the brains of patients, opening exciting possibilities for replacing lost neurons.